MELASCEND

Chemical preparations for pharmaceutical or medical purposes, namely, for autism spectrum disorders and Alzheimer's disorder; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autism spectrum disorders and Alzheimer's disorder; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autism spectrum disorders and Alzheimer's disorder; Pharmaceutical preparations for autism spectrum disorders and Alzheimer's disorder